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for SREBP-1 activation (Okazaki et al.,
2010; Xu et al., 2010).
It is remarkable that the connection
between SREBP and the folate cycle
and homocysteine metabolism was not
found sooner, given the previous microar-
ray analysis of different transgenic and
knockout mouse models in the SREBP
pathway (Horton et al., 2003). Using these
transgenic models, it will be interesting to
investigate how SREBP-1-mediated
changes in the one-carbon cycle impact
other methylation-dependent processes
such as DNA methylation (Blom and
Smulders, 2011). Given the known link
between metabolism and epigenetics,this may open the door on another very
interesting chapter in SREBP biology.
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The Parkinson’s disease proteins PINK1 and Parkin are proposed guardians of mitochondrial
fidelity, targeting damaged mitochondria for degradation by mitophagy. In this issue of Cell,
Wang et al. (2011) now show that PINK1 and Parkin also regulate mitochondrial trafficking and
quarantine damaged mitochondria by severing their connection to the microtubule network.To maintain the mitochondrial network
in good working order, mitochondria un-
dergo continuous cycles of fission and
fusion, promoting the redistribution of
refurbished contents throughout the
system. Sometimes, however, mitochon-
dria can become too badly damaged to
be rescued by this cycle and must be
culled from the network. We now under-
stand that these damaged organelles can
be recycled by a form of mitochondrial
autophagy known as mitophagy. Two
proteins known to be mutated in certain
forms of early onset Parkinson’s disease,
the E3 ubiquitin ligase Parkin and the
serine/threonine kinase PINK1, mediate
mitophagy following mitochondrial dam-
age and target specific substrates for pro-teasomal degradation (Deas et al., 2011;
Kawajiri et al., 2011). In this issue of Cell,
Wang et al. (2011) identify the mitochon-
drial outer-membrane protein Miro as
a substrate of PINK1 and show that it is
degraded through a Parkin-dependent
mechanism. Destruction of Miro unhooks
damaged mitochondria from the microtu-
bule network, preventing their transport
throughout the cell.
Previous studies have shown that the
PINK1/Parkin mitochondrial surveillance
pathway is activated when degradation
of PINK1 is inhibited, leading to an
increase in the abundance of PINK1 on
the mitochondrial outer membrane. This
increase results in the recruitment of Par-
kin to mitochondria by a kinase-depen-dent mechanism. Once present on mito-
chondria, Parkin ubiquitinates a subset
of protein targets, leading to their protea-
somal degradation and ultimately the
destruction of the entire damaged organ-
elle via mitophagy (Figure 1). As PINK1
and Parkin mutations are linked to neuro-
degeneration in Parkinson’s disease, the
study by Wang et al. adds the important
finding that Parkin is recruited to
damaged mitochondria not only in
cultured cell lines (Narendra et al., 2008),
but also in primary neurons.
Now, Miro has been identified as
a PINK1 substrate. Miro is a Rho-like
GTPase that plays an important role in
the movement of mitochondria within
cells. It is anchored by a single C-terminalovember 11, 2011 ª2011 Elsevier Inc. 721
Figure 1. Miro in Mitochondrial Autophagy
(A) In cells with healthy mitochondria, Miro and its binding partners connect
mitochondria to microtubules, facilitating trafficking of the organelles to
various cellular locations.
(B) Upon mitochondrial damage, PINK1 levels are stabilized on the outer
membrane, resulting in the recruitment of Parkin and modification of Miro. The
inset shows the PINK1/Parkin/Miro complex described by Wang et al.
(C) Through phosphorylation, ubiquitination, and proteasomal pathways, Miro
is degraded. The stationary damaged mitochondrion is segregated and can
then undergo mitophagy.transmembrane domain in the
outer mitochondrial mem-
brane and has two GTPase
domains and two EF hands
that face the cytosol and are
critical for Miro function
(Fransson et al., 2003; Freder-
ick et al., 2004). The protein
connects mitochondria to
microtubules via its binding
partners Milton and kinesin
heavy chain (KHC) and is
required for mitochondrial
transport. Neuronal cells in
particular depend on efficient
trafficking of mitochondria to
supply distant subcellular
locations between the cell
body and the axon terminal,
and defects in this process
are associated with neuron
dysfunction (Guo et al., 2005).
The study in this issue by
Wang et al. made the initial
observation that overexpres-
sion of PINK1 or Parkin in
cultured mouse or fly neurons
results in arrest of mitochon-
drial motion. Because the
Miro/Milton/KHC complex is
the most characterized path-
way involved in mitochondrial
movement and Miro and its
partner Milton can bind to
PINK1 (Weihofen et al.,
2009), the authors studied
the connection between Miro
and the PINK1/Parkin path-
way. They found that Miro
can be directly phosphory-
lated by PINK1 and that,
upon damage to mitochon-
dria, Miro is degraded in a
Parkin-dependent manner.
The authors also identify aPINK1/Parkin/Miro complex (Figure 1).
This suggests that Miro is a substrate
and binding partner of both PINK1 and
Parkin. The final outcome of the modi-
fication and degradation of Miro is the
arrest and segregation of damaged
mitochondria prior to their degradation
by mitophagy, thus protecting the healthy
mitochondrial network.
Along with its role in mitochondrial traf-
ficking, Miro (and its yeast homolog
Gem1p) has now been localized to mito-
chondria-ER contact sites (Kornmann722 Cell 147, November 11, 2011 ª2011 Elseet al., 2011). These structures play
multifaceted roles in the maintenance of
the lipid bilayers of both organelles and
are important locations for calcium
release and signaling. One might spec-
ulate that, in addition to halting mito-
chondrial traffic, Miro degradation by
the PINK1/Parkin pathway may also
free the ER from mitochondrial tethers.
This secondary role might protect the
ER from damaged mitochondria, and
the loss of ER contacts may facilitate
mitophagy.vier Inc.Because Parkin and PINK1
were first implicated in mi-
tophagy, there have been
many models to explain
precisely what their role is in
this process. However, there
is little consensus on how
PINK1 recruits Parkin or how
Parkin-tagged mitochondria
are recognized by autopha-
gosomes. One hypothesis is
that Parkin recruitment is
a result of direct phosphoryla-
tion and/or binding by PINK1.
It has also been suggested
that these two enzymes may
have shared substrates and
that phosphorylation of these
substrates by PINK1 leads to
the recruitment of Parkin.
The discovery that Miro is
bound by PINK1 and Parkin
and is likely a substrate of
both adds weight to the latter
‘‘shared substrate’’ hypoth-
esis. Given the number of Par-
kin substrates on the mito-
chondrial outer membrane, it
is unlikely that Miro is unique
in this respect. The study by
Wang et al. not only reveals
a glimpse into how PINK1
and Parkin cooperate, but
also shows that mitochondrial
quality control systems can
directly alter mitochondrial
transport and raises the
possibility that one aspect of
Parkinson’s disease is the
inappropriate trafficking of
damaged mitochondria.
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